International Flavors & Fragrances Inc (IFF) stock
Close on Oct 30, 2026Market cap $23.73BP/E –Yield 1.72%
Earnings
International Flavors & Fragrances's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of International Flavors & Fragrances's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q3 FY2026ended Sep 30, 2026 | Nov 3, 2026Expected | – | – | – | – | – |
| Q2 FY2026ended Jun 30, 2026 | Aug 4, 2026during market hours | $1.95B | -29.3% | $0.13 | $0.82 | Release |
| Q1 FY2026ended Mar 31, 2026 | May 5, 2026during market hours | $2.74B | -3.5% | $0.66 | $1.25 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 11, 2026during market hours | $2.59B | -6.5% | $0.07 | $0.80 | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 4, 2025during market hours | $2.69B | -8.2% | $0.16 | $1.05 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 5, 2025during market hours | $2.76B | -4.5% | $2.38 | $1.15 | Release |
| Q1 FY2025ended Mar 31, 2025 | May 6, 2025during market hours | $2.84B | -2.1% | -$3.98 | $1.20 | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 18, 2025during market hours | $2.77B | +2.6% | -$0.18 | $0.97 | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 5, 2024during market hours | $2.93B | +3.9% | $0.23 | $1.04 | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 6, 2024during market hours | $2.89B | -1.4% | $0.66 | $1.16 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 6, 2024during market hours | $2.90B | -4.3% | $0.23 | $1.13 | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 20, 2024during market hours | $2.70B | -4.9% | -$10.21 | $0.72 | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 6, 2023during market hours | $2.82B | -7.8% | $0.10 | $0.89 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 7, 2023during market hours | $2.93B | -11.5% | $0.11 | $0.86 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 8, 2023during market hours | $3.03B | -6.2% | -$0.04 | $0.87 | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 8, 2023during market hours | $2.84B | -6.3% | $0.01 | $0.97 | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 7, 2022during market hours | $3.06B | -0.3% | -$8.60 | $1.36 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 8, 2022during market hours | $3.31B | – | $0.43 | $1.54 | Release |
| Q1 FY2022ended Mar 31, 2022 | May 9, 2022during market hours | $3.23B | – | $0.96 | $1.69 | Release |
| Q4 FY2021ended Dec 31, 2021 | Feb 9, 2022during market hours | $3.03B | – | $0.35 | $1.10 | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 8, 2021during market hours | $3.07B | – | $0.76 | $1.47 | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 5, 2021during market hours | – | – | – | – | Release |
| Q1 FY2021ended Mar 31, 2021 | May 10, 2021during market hours | – | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Jan 26, 2021before the open | – | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Nov 9, 2020during market hours | – | – | – | – | Filing |
| Q2 FY2020ended Jun 30, 2020 | Aug 10, 2020during market hours | – | – | – | – | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
International Flavors & Fragrances's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| comparable currency neutral sales growthnon-GAAP | FY2026 | +2% – +4% | +1% – +4% | Raised | Aug 4, 2026 |
| salesGAAP | FY2026 | $7.40B – $7.60B | – | New | Aug 4, 2026 |
| sales | FY2026 | $10.50B – $10.80B | $10.50B – $10.80B | Reaffirmed | May 5, 2026 |
| comparable currency neutral sales growthnon-GAAP | FY2026 | +1% – +4% | – | New | May 5, 2026 |
| adjusted operating EBITDAnon-GAAP | FY2026 | $1.53B – $1.60B | $2.05B – $2.15B | Lowered | Aug 4, 2026 |
| comparable currency neutral adjusted operating EBITDA growthnon-GAAP | FY2026 | +4% – +8% | +3% – +8% | Raised | Aug 4, 2026 |
| comparable currency neutral adjusted operating EBITDA growthnon-GAAP | FY2026 | +3% – +8% | – | New | May 5, 2026 |
Guidance vs results
The last range International Flavors & Fragrances gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2025 | Revenue | $10.60B – $10.90B | $10.88BΣ4Q | Within range |
| Q2 FY2023 | Revenue | $3.00B – $3.10B | $2.93B | Below range |
Guidance history
Every forecast International Flavors & Fragrances put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Aug 4, 2026 | comparable currency neutral adjusted operating EBITDA growth | FY2026 | +4% – +8% | Raised |
| Aug 4, 2026 | adjusted operating EBITDA | FY2026 | $1.53B – $1.60B | Lowered |
| Aug 4, 2026 | comparable currency neutral sales growth | FY2026 | +2% – +4% | Raised |
| Aug 4, 2026 | sales | FY2026 | $7.40B – $7.60B | New |
| May 5, 2026 | comparable currency neutral sales growth | FY2026 | +1% – +4% | New |
| May 5, 2026 | adjusted operating EBITDA | FY2026 | $2.05B – $2.15B | Reaffirmed |
| May 5, 2026 | comparable currency neutral adjusted operating EBITDA growth | FY2026 | +3% – +8% | New |
| May 5, 2026 | sales | FY2026 | $10.50B – $10.80B | Reaffirmed |
| Feb 11, 2026 | Comparable currency neutral adjusted operating EBITDA | FY2026 | +3% – +8% | New |
| Feb 11, 2026 | adjusted operating EBITDA | FY2026 | $2.05B – $2.15B | New |
| Feb 11, 2026 | comparable currency neutral sales growth | FY2026 | +1% – +4% | New |
| Feb 11, 2026 | sales | FY2026 | $10.50B – $10.80B | New |
| Nov 4, 2025 | growth in comparable currency neutral adjusted operating EBITDA | FY2025 | +5% – +10% | Reaffirmed |
| Nov 4, 2025 | adjusted operating EBITDA | FY2025 | $2.00B – $2.15B | Reaffirmed |
| Nov 4, 2025 | comparable currency neutral sales growth | FY2025 | +1% – +4% | Reaffirmed |
| Nov 4, 2025 | sales | FY2025 | $10.60B – $10.90B | New |
| Aug 5, 2025 | growth in comparable currency neutral adjusted operating EBITDA | FY2025 | +5% – +10% | New |
| Aug 5, 2025 | adjusted operating EBITDA | FY2025 | $2.00B – $2.15B | New |
| Aug 5, 2025 | comparable currency neutral sales growth | FY2025 | +1% – +4% | New |
| Aug 5, 2025 | sales | FY2025 | $10.60B – $10.90B | New |
| May 6, 2025 | comparable currency neutral adjusted operating EBITDA | FY2025 | +5% – +10% | Reaffirmed |
| May 6, 2025 | adjusted operating EBITDA | FY2025 | $2.00B – $2.15B | Reaffirmed |
| May 6, 2025 | comparable currency neutral sales growth | FY2025 | +1% – +4% | Reaffirmed |
| May 6, 2025 | sales | FY2025 | $10.60B – $10.90B | Reaffirmed |
| Feb 18, 2025 | Comparable currency neutral adjusted operating EBITDA | FY2025 | +5% – +10% | New |
| Feb 18, 2025 | adjusted operating EBITDA | FY2025 | $2.00B – $2.15B | New |
| Feb 18, 2025 | comparable currency neutral sales growth | FY2025 | +1% – +4% | New |
| Feb 18, 2025 | sales | FY2025 | $10.60B – $10.90B | New |
| Nov 5, 2024 | adjusted operating EBITDA | FY2024 | $2.17B | Raised |
| Nov 5, 2024 | foreign exchange adverse impact to sales growth | FY2024 | 3% | Lowered |
| Nov 5, 2024 | volume | FY2024 | +5% – +6% | Raised |
| Nov 5, 2024 | sales | FY2024 | $11.30B – $11.40B | Raised |
| Aug 6, 2024 | adjusted operating EBITDA | FY2024 | $2.10B – $2.17B | Raised |
| Aug 6, 2024 | foreign exchange | FY2024 | 3% – 4% | New |
| Aug 6, 2024 | Pricing | FY2024 | +1% | Lowered |
| Aug 6, 2024 | volume | FY2024 | +3% – +5% | New |
| Aug 6, 2024 | sales | FY2024 | $11.10B – $11.30B | New |
| May 6, 2024 | adjusted operating EBITDA | FY2024 | $1.90B – $2.10B | Reaffirmed |
| May 6, 2024 | sales | FY2024 | $10.80B – $11.10B | Reaffirmed |
| Feb 20, 2024 | adjusted operating EBITDA | FY2024 | $1.90B – $2.10B | New |
| Feb 20, 2024 | sales | FY2024 | $10.80B – $11.10B | New |
| Nov 6, 2023 | adjusted operating EBITDA | FY2023 | $1.85B – $2.00B | Reaffirmed |
| Nov 6, 2023 | sales | FY2023 | $11.30B – $11.60B | Lowered |
| Aug 7, 2023 | adjusted operating EBITDA | FY2023 | $1.85B – $2.00B | Lowered |
| Aug 7, 2023 | sales | FY2023 | $11.30B – $11.60B | Lowered |
| May 8, 2023 | adjusted operating EBITDA | Q2 FY2023 | $540.00M – $590.00M | New |
| May 8, 2023 | adjusted operating EBITDA | FY2023 | $2.34B | Reaffirmed |
| May 8, 2023 | Comparable currency neutral sales growth | FY2023 | +5% | New |
| May 8, 2023 | sales | Q2 FY2023 | $3.00B – $3.10B | New |
| May 8, 2023 | sales | FY2023 | $12.30B | New |
| Feb 8, 2023 | Comparable currency neutral sales growth | FY2023 | +6% | New |
| Feb 8, 2023 | adjusted operating EBITDA | FY2023 | $2.34B | New |
| Feb 8, 2023 | sales | FY2023 | $12.50B | New |
| Nov 7, 2022 | comparable currency neutral sales growth | FY2022 | +9% – +10% | New |
| Nov 7, 2022 | comparable currency neutral adjusted operating EBITDA growth | FY2022 | +4% – +8% | Reaffirmed |
| Nov 7, 2022 | adjusted operating EBITDA | FY2022 | $2.50B – $2.60B | Reaffirmed |
| Nov 7, 2022 | sales | FY2022 | $12.40B – $12.50B | Lowered |
| Aug 8, 2022 | adjusted operating EBITDA | FY2022 | $2.50B – $2.60B | Reaffirmed |
| Aug 8, 2022 | sales | FY2022 | $12.60B – $13.00B | Reaffirmed |
| May 9, 2022 | comparable currency neutral adjusted operating EBITDA growth | FY2022 | +4% – +8% | New |
| May 9, 2022 | adjusted operating EBITDA | FY2022 | $2.50B – $2.60B | Reaffirmed |
| May 9, 2022 | comparable currency neutral sales growth | FY2022 | +9% – +12% | New |
| May 9, 2022 | sales | FY2022 | $12.60B – $13.00B | New |
| Feb 9, 2022 | adjusted operating EBITDA | FY2022 | $2.50B – $2.60B | New |
| Feb 9, 2022 | sales | FY2022 | $12.30B – $12.70B | New |
| Nov 8, 2021 | Adjusted Operating EBITDA Margin 5 | FY2021 | 21% | New |
| Nov 8, 2021 | Sales | FY2021 | $11.55B | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases International Flavors & Fragrances filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Results
- News
- Results
- Results
- Results
- Results
- Results
- Update
- Results
- Results
- Results
- Results
- Update
- Results